New Chairman of the Main Board of ARPharM was Elected
At a regular meeting of the General Assembly of the Association of the Research-based Pharmaceutical Manufacturers in Bulgaria (ARPharM), held on May 19, 2022, two new members of the Association's Management Board (MB) were elected.
Dr. Stamen Bankovski, director for Bulgaria, Romania, and Hungary of the pharmaceutical company Astellas, was elected Chairman of the ARPharM Main Board.
The other new member of the Main Board is Dr. Boryana Alexieva - Head of Relations with Governmental Structures, Institutions and Patient Organizations in Janssen - the pharmaceutical companies of Johnson & Johnson, Bulgaria.
The new figures in the management of ARPharM will continue the organisation's efforts in the direction of improving Bulgarian patients' access to quality, modern and effective medical treatment and will cooperate with all state institutions and patient organisations for the preparation of balanced policies to improve the healthcare system in our country.